News & Blog

From the CEO’s Desk: Entering May with Momentum

For our community, May is perhaps of the most important month of the year. It’s a month that the entire brain tumor community in the United States – patients, survivors, caregivers, patient advocacy groups, families, friends, and other loved ones affected by this disease – come together to “Go Gray in May” for National Brain […]

May is Brain Tumor ACTION Month

In three days, Brain Tumor Awareness Month 2016 kicks off in the United States. But this time around, our neighbors to the North are joining with us and moving their annual month of awareness to May as well. It’s been wonderful to see our community cross international lines and unify to be the voice for […]

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

Share